IO Biotech Q3 2025 Earnings EPS Beats Estimates by 6067 as Narrowing Losses Highlight Cost Discipline CVR Energy Q1 2026 Earnings Substantial EPS Miss Amid Challenging Refining Environment Mesoblast Q1 2026 Earnings Narrower Loss Surprises on Cost Discipline Stock Gains ETOR Q1 2026 Earnings Earnings Beat Expectations with 2342 Surprise CHCI Q1 2008 Earnings Significant EPS Miss Despite Stock Rally CRBP Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances